Skip to main content

Search articles in

Found 3,079 articles

  • The Evolution of Clinical Data Management

    The Evolution of Clinical Data Management

    • 10 Apr 2024
    • Lucy Walters

    Clinical Data Management (CDM) has drastically transformed over the years, proactively adapting to technological advancements, changing regulations, and the growing complexity of clinical trials.

  • Eli Lilly's and AstraZeneca's former head of resea

    Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg invests in AlzeCure and is proposed for election to its board

    • 10 Apr 2024
    • Editor

    AlzeCure Pharma AB (”AlzeCure” or ”the Company”), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, today announced that Professor Jan Lundberg invests in the company and is proposed as a new member of the company's board of directors.

  • Cambridge Cognition strengthens senior management

    Cambridge Cognition strengthens senior management team to deliver growth

    • 10 Apr 2024
    • Editor

    Cambridge Cognition, a leader in digital health solutions for brain health assessment, has announced the appointments of Alex Livingstone-Learmonth as Chief Commercial Officer and Annabelle Miles as Head of Marketing.

  • Qnovia, Inc. Announces the Appointment of Four New

    Qnovia, Inc. Announces the Appointment of Four New Members to its Scientific Advisory Board

    • 10 Apr 2024
    • Editor

    Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced the appointment of four new members to its Scientific Advisory Board (SAB).

  • Bayer and Google Cloud Collaborate to Bring Respon

    Bayer and Google Cloud Collaborate to Bring Responsible AI Solutions to Radiologists

    • 9 Apr 2024
    • Editor

    Bayer and Google Cloud today announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients.

  • About ProteoNic

    About ProteoNic

    • 9 Apr 2024
    • Editor

    ProteoNic is a privately held company with offices in Leiden, the Netherlands and in the Boston area, USA. The company offers technology and services for the generation of cell lines and viral vectors with greatly improved production characteristics.

  • Thermo Fisher Scientific Launches New ENERGY STAR

    Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times

    • 9 Apr 2024
    • Editor

    Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low temperature (ULT) freezers.

  • Labcorp Announces Expansion of Precision Oncology

    Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs

    • 9 Apr 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the strategic expansion of its precision oncology portfolio, solidifying its commitment to advancing cancer research and patient care on a global scale.

  • What Does the New UK Employment Legislation Mean f

    What Does the New UK Employment Legislation Mean for Life Science Employers?

    • 9 Apr 2024
    • Lucy Walters

    New legislation and associated employment regulations came into force on the 6th of April, changing how employers manage flexible working, carer’s leave, and redundancy in the UK.

  • Top Ten Companies Hiring in April 2024

    Top Ten Companies Hiring in April 2024

    • 8 Apr 2024
    • Nola Cadman

    Here's a list of the top pharma and life science companies hiring in April on PharmiWeb.jobs

  • Top Ten Recruiters Hiring in April 2024

    Top Ten Recruiters Hiring in April 2024

    • 8 Apr 2024

    Here are the top Pharma and Life Science recruitment organisations advertising in April 2024 on PharmiWeb.jobs

  • About Vector Pharma

    About Vector Pharma

    • 8 Apr 2024
    • Editor

    Vector Pharma was founded in 2019 with the ambition to be the leading full service distributor for rare diseases, oncology and highly specialized therapeutics in the Middle East, North Africa, and Turkish markets.

  • 9 Clinical Data Management Career Paths

    9 Clinical Data Management Career Paths

    • 8 Apr 2024
    • Lucy Walters

    As the life science industry becomes increasingly data-driven, the field of clinical data management (CDM) is expanding, offering a wealth of career opportunities for those interested in leveraging data to improve patient outcomes and healthcare processes.

  • Results announced from EMPACT-MI phase III trial i

    Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack

    • 8 Apr 2024
    • Editor

    The EMPACT-MI phase III clinical trial showed a 10% relative risk reduction in the primary composite endpoint of time to first hospitalization due to heart failure or all-cause mortality for empagliflozin versus placebo, which did not reach statistical significance.

  • Enhertu approved in the US as first tumour-agnosti

    Enhertu approved in the US as first tumour-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumours

    • 8 Apr 2024
    • Editor

    AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumours who have received prior systemic treatment and have no satisfactory alternative treatment options.

  • About EnteroBiotix

    About EnteroBiotix

    • 5 Apr 2024
    • Editor

    EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics for patients with serious unmet medical needs. The Company is leveraging its product platform to address patient needs through a pipeline of tailored high-diversity products that fortify and restore the microbiome.

  • A Recruiter’s Guide to Hiring a Clinical Data Mana

    A Recruiter’s Guide to Hiring a Clinical Data Manager

    • 5 Apr 2024
    • Lucy Walters

    From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will provide you with valuable tips to help you focus your candidate search and engage top talent.

  • Parexel Named “Best Contract Research Organization

    Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards

    • 5 Apr 2024
    • Editor

    Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been named “Best Contract Research Organization” at the 17th Annual Vaccine Industry Excellence (ViE) Awards.

  • Artificial Intelligence and Machine Learning in Cl

    Artificial Intelligence and Machine Learning in Clinical Data Management: Opportunities and Ethical Considerations

    • 4 Apr 2024
    • Lucy Walters

    Artificial Intelligence (AI) and Machine Learning (ML) promise to revolutionise how clinical data is collected, analysed, and utilised, offering unprecedented opportunities for enhancing trial efficiency and patient outcomes.

  • Phase 1/2 Interim Data on Moderna’s mRNA-3927, an

    Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature

    • 4 Apr 2024
    • Editor

    Moderna, Inc. (NASDAQ:MRNA) today announced that interim data for a first-in-human, phase 1/2, open-label, dose optimization study and extension study, evaluating the safety and efficacy of mRNA-3927, an investigational mRNA therapy for propionic acidemia (PA), has been published in Nature.